Discover investment opportunities in Top 5 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 5 Stocks Under $1 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 5 Stocks Under $1 using our Smart AI Filter.
7 stocks found for "Top 5 Stocks Under $1"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.11 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield | |||
0.76 Risk measure | ±100.0% Price volatility | -0.1 Valuation | 0.00% Annual yield | |||
1.01 Risk measure | ±72.3% Price volatility | -3.1 Valuation | 0.00% Annual yield | |||
1.19 Risk measure | ±71.0% Price volatility | -1.1 Valuation | 0.00% Annual yield | |||
0.65 Risk measure | ±93.4% Price volatility | -1.0 Valuation | 0.00% Annual yield | |||
0.64 Risk measure | ±100.0% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
0.15 Risk measure | ±100.0% Price volatility | -0.2 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Oncolytics Biotech (ONCY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read moreKaixin Auto Holdings (NASDAQ: KXIN) revealed that Beijing Camping Club Sports and Culture Communication Co Ltd (Camping Club) has agreed to order about 20,000 new energy vehicles over the next five years. The value of the order totals RMB6 billion ($938 million).
Read moreQ: How does KXIN perform in volatile markets?
A: KXIN, like many small-cap stocks, may experience heightened volatility due to its lower price point and market capitalization. Historically, penny stocks such as KXIN can be more susceptible to market swings, offering both risks and opportunities for investors.
Q: Does VTAK offer any income potential through dividends?
A: VTAK does not currently offer dividends. Investors seeking income potential should consider reviewing the financial health and strategic goals of companies to assess potential future dividend offerings.
Q: What sector does NUWE belong to, and what are its potential growth drivers?
A: NUWE is in the biotechnology sector, where potential growth drivers include advancements in drug development, favorable regulatory approvals, and market demand for innovative healthcare solutions.
Q: Is VXRT involved in any significant R&D projects?
A: VXRT, a biotechnology company, is known for focusing on oral vaccines. Current R&D projects often center on developing vaccines for infectious diseases, presenting potential growth opportunities as these vaccines gain regulatory approval.
Q: What are the main risks associated with investing in ONCY?
A: ONCY, being a clinical-stage biotechnology company, faces risks such as clinical trial failures, regulatory hurdles, and competition from industry peers. These factors can significantly impact stock performance.
Q: How does HCTI's market position affect its competitive advantages?
A: HCTI's position in the healthcare technology sector can offer competitive advantages through innovation and intellectual property. However, competition from larger players may pose challenges in market share expansion.